A new trading day began on Friday, with Adaptive Biotechnologies Corp (NASDAQ: ADPT) stock price down -5.41% from the previous day of trading, before settling in for the closing price of $7.77. ADPT’s price has ranged from $2.28 to $8.95 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 17.92%. Meanwhile, its annual earnings per share averaged 14.13%. With a float of $141.69 million, this company’s outstanding shares have now reached $147.77 million.
Let’s determine the extent of company efficiency that accounts for 619 employees. In terms of profitability, gross margin is 58.17%, operating margin of -86.43%, and the pretax margin is -89.17%.
Adaptive Biotechnologies Corp (ADPT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Adaptive Biotechnologies Corp is 3.14%, while institutional ownership is 92.61%. The most recent insider transaction that took place on Mar 05 ’25, was worth 145,845. In this transaction Chief People Officer of this company sold 20,875 shares at a rate of $6.99, taking the stock ownership to the 332,846 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Chief Commercial Officer, MRD sold 26,023 for $6.98, making the entire transaction worth $181,641. This insider now owns 347,238 shares in total.
Adaptive Biotechnologies Corp (ADPT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.13% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.66% during the next five years compared to -1.51% drop over the previous five years of trading.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Here are Adaptive Biotechnologies Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.08, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corp (ADPT)
Looking closely at Adaptive Biotechnologies Corp (NASDAQ: ADPT), its last 5-days average volume was 2.42 million, which is a jump from its year-to-date volume of 1.67 million. As of the previous 9 days, the stock’s Stochastic %D was 43.10%. Additionally, its Average True Range was 0.70.
During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 65.81%, which indicates a significant increase from 25.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.29% in the past 14 days, which was lower than the 80.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.50, while its 200-day Moving Average is $5.33. However, in the short run, Adaptive Biotechnologies Corp’s stock first resistance to watch stands at $7.82. Second resistance stands at $8.29. The third major resistance level sits at $8.66. If the price goes on to break the first support level at $6.98, it is likely to go to the next support level at $6.61. Now, if the price goes above the second support level, the third support stands at $6.14.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats
With a market capitalization of 1.09 billion, the company has a total of 148,582K Shares Outstanding. Currently, annual sales are 178,960 K while annual income is -159,490 K. The company’s previous quarter sales were 47,460 K while its latest quarter income was -33,690 K.
